Bahrain vs Syrian Arab Republic: Share of people with HIV who receive antiretroviral therapy
Bahrain
55.0%
in 2024
Syrian Arab Republic
55.0%
in 2024
Bahrain rank
112th
Syrian Arab Republic rank
112th
Share of people with HIV who receive antiretroviral therapy over time
- Bahrain
- Syrian Arab Republic
How they compare
Bahrain currently reports 55.0% against 55.0% in Syrian Arab Republic, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 112th and Syrian Arab Republic ranks 112th of 143 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.3% | 3.0% | 11.3% | Bahrain |
| 2010s | 35.4% | 22.3% | 13.1% | Bahrain |
| 2020s | 55.2% | 48.8% | 6.4% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Bahrain or Syrian Arab Republic?
- Bahrain, at 55.0% against 55.0% in Syrian Arab Republic as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Bahrain and Syrian Arab Republic?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Syrian Arab Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and Syrian Arab Republic rank globally for share of people with hiv who receive antiretroviral therapy?
- Bahrain ranks 112th and Syrian Arab Republic ranks 112th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.